U.S. lawmakers question high drug prices to CEO of Ozempic and Wegovy
The high price of some popular weight loss drugs is at the center of a congressional committee on Tuesday with a pharmaceutical executive in the hot seat.
Stephanie Stahl reports more on the price concerns.
